Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112720 · ClinicalTrials.gov registry record · Phase 3
Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 3
- Development phase
- 8
- Enrollment target
NCT03112720: Clinical Trial Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
NCT03112720 is a Phase 3 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 8 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112720, a Phase 3 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches
Primary Outcome
Outcome measure will entail recording patient self-reported pain scores to quantify the level of headache pain using the Visual analog scale, meaning 0 - No pain, 1-3 - Mild Pain, 4-6 - Moderate Pain, 7-10 - Severe Pain, by way of in person assessment by pain questionnaire just prior to initiation of either therapy (Epidural blood patch vs Sphenopalatine Ganglion Block).
Interventions
- DEVICE Epidural Blood Patch
- DRUG Sphenopalatine Ganglion Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-09 |
| Phase | Phase 3 |
Why NCT03112720 stopped before completion
NCT03112720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Epidural Blood Patch is the first listed.
NCT03112720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03112720 about?
NCT03112720 is a clinical study titled "Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache". The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches
What is the current status of trial NCT03112720?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 8 participants. The study started on 2016-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT03112720?
The interventions under investigation include: Epidural Blood Patch (DEVICE), Sphenopalatine Ganglion Block (DRUG).
Who is sponsoring clinical trial NCT03112720?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03112720's enrollment target sits among peer trials
8 1993rd of 2000 higher than 6 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia